Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. [electronic resource]
Producer: 20080331Description: 8-15 p. digitalISSN:- 0920-9964
- Adolescent
- Adult
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Dibenzothiazepines -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Patient Readmission -- statistics & numerical data
- Piperazines -- adverse effects
- Proportional Hazards Models
- Quetiapine Fumarate
- Quinolones -- adverse effects
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Risk Factors
- Risperidone -- adverse effects
- Schizophrenia -- diagnosis
- Schizophrenia, Paranoid -- diagnosis
- Schizophrenic Psychology
- Sensitivity and Specificity
- Substance Withdrawal Syndrome -- epidemiology
- Survival Rate
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.